Dr Arnab Ghosh

Dr. Arnab Ghosh is a cancer researcher and Marion McCormack Research Fellow at the Flinders Health and Medical Research Institute (FHMRI), Flinders University, Adelaide. His work is driven by a single, powerful conviction, that every woman deserves the chance to detect cancer early, when treatment works best and survival outcomes are at their highest.

Dr. Ghosh completed his PhD in Reproductive Biology at the University of Newcastle in 2019, where his landmark discovery identifying the stem cells of the fallopian tube and their role in the earliest origins of ovarian cancer was published in the prestigious journal Development, fundamentally changing our understanding of how gynaecological cancers begin.

Before joining Flinders, Dr. Ghosh completed a Research Fellowship at Mayo Clinic in Rochester, USA, one of the world's most renowned medical institutions, where he worked at the cutting edge of translational cancer research. At Mayo Clinic, he contributed towards developing a breast cancer organoid biobank initiative, working alongside surgeons, oncologists, and scientists to grow miniature tumour models from patient biopsy samples. This combination of laboratory and clinical experience has positioned him as a scientist who can take discoveries from the bench directly to the bedside.

One of Dr. Ghosh's key areas of expertise is organoid technology, a revolutionary technique where miniature, three-dimensional replicas of tumours are grown in the laboratory from a patient's own tissue. Think of these as tiny living models of a patient's cancer, grown outside the body. These structures mirror the real tumour with extraordinary accuracy and can predict how a patient will respond to treatment offering a powerful alternative to trial-and-error medicine. Because these models can be developed from minute surgical biopsy samples, they hold enormous potential for large-scale drug screening, enabling researchers to test hundreds of therapeutic candidates rapidly. Dr. Ghosh is harnessing this technology to identify novel biomarkers for early diagnosis and personalised treatment, helping match the right therapy to the right patient at the right time.

At Flinders, his research is focused on gynaecological cancers, particularly ovarian and endometrial cancer, two diseases notoriously difficult to diagnose early. His goal is to uncover the biological signals at the very earliest stages of cancer and translate these into diagnostic and therapeutic tools that could one day transform patient outcomes and save thousands of lives.

His research has been published in world-leading journals including Development, Cell Reports, Cell Stem Cell, PNAS, Nature Communications, and Cell Reports Medicine.